About
Ali Siam is a biotech business executive and the Chief Business Officer of Rubedo Life Sciences, a longevity-focused biopharmaceutical company developing therapies for age-related diseases. Rubedo says he leads business development and corporate strategy. Before Rubedo, he was CBO at Celmatix and previously held strategy and commercialization roles at L.E.K. Consulting, AbbVie, Johnson & Johnson, and Boston Scientific.
Areas of interest
longevitybiotechage-related disease therapeuticsdrug discoverybusiness developmentcorporate strategypharma partnershipshealthcare commercializationwomen's health